Guatemala vs Peru: Cause of death, by non-communicable diseases, ages 60+, male
Guatemala
38.1%
in 2021
Peru
36.7%
in 2021
Guatemala rank
181st
Peru rank
182nd
Cause of death, by non-communicable diseases, ages 60+, male over time
- Guatemala
- Peru
How they compare
Guatemala currently reports 38.1% against 36.7% in Peru, a difference of 1.4%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Peru ahead.
Guatemala ranks 181st and Peru ranks 182nd of 185 countries.
Across the 3 decades both report, Guatemala averaged higher in 2 and Peru in 1.
Head to head by decade
| Decade | Guatemala | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 64.0% | 71.2% | 7.2% | Peru |
| 2010s | 76.9% | 71.0% | 5.9% | Guatemala |
| 2020s | 50.4% | 41.5% | 8.8% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Guatemala or Peru?
- Guatemala, at 38.1% against 36.7% in Peru as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Guatemala and Peru?
- 1.4%, with Guatemala ahead.
- How many years of comparable data are there for Guatemala and Peru?
- 6 years are reported by both, from 2000 to 2021.
- How do Guatemala and Peru rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Guatemala ranks 181st and Peru ranks 182nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.